Group 1 - Kaizhong Precision plans to invest up to 250 million yuan to establish a subsidiary and build a production base in Thailand, focusing on overseas connector and precision component business [1] - Longbo Technology reported a 60.18% year-on-year increase in net profit for the first half of 2025, with revenue of 122 million yuan, up 18.03% [2] - Dingyang Technology achieved a net profit of 76.88 million yuan in the first half of 2025, a year-on-year increase of 31.54%, with revenue of 279 million yuan, up 24.61% [4] Group 2 - Heng Rui Pharmaceutical received approval for clinical trials of two drugs, SHR-A2102 and Adebeli monoclonal antibody injection [6] - Maolai Optical plans to use up to 100 million yuan of idle funds for entrusted wealth management to improve fund utilization efficiency [8] - Shiji Information signed a major contract with MGM Grand, providing a next-generation cloud-based hotel information management system [7] Group 3 - Yunnan Germanium's subsidiary received a government subsidy of 6.8 million yuan related to revenue [9] - Jizhi Co. received a warning letter from the Zhejiang Securities Regulatory Bureau for failing to disclose significant government subsidies [10] - Dongfang Precision reported a net profit of approximately 397 million yuan for the first half of 2025, a year-on-year increase of 142.52% [11] Group 4 - Aolaide expects a net profit decrease of 68.41% to 72.77% for the first half of 2025, with revenue projected between 270 million and 290 million yuan [12] - Feilong Co. used 111 million yuan of idle funds for cash management through structured deposit products [13] - Anhui Construction won two major projects with a total investment exceeding 6.6 billion yuan [15] Group 5 - Yunnan Germanium's subsidiary received a government subsidy of 6.8 million yuan related to revenue [9] - Jizhi Co. received a warning letter from the Zhejiang Securities Regulatory Bureau for failing to disclose significant government subsidies [10] - Dongfang Precision reported a net profit of approximately 397 million yuan for the first half of 2025, a year-on-year increase of 142.52% [11] Group 6 - China Medical's subsidiary received approval for the listing of fumaric acid volnora raw materials [20] - Huayuan Vaccine's subsidiary received approval for clinical trials of Hib vaccine [29] - Ganfeng Lithium plans to integrate lithium salt lake projects in Argentina and provide financial support of up to 130 million USD [41]

本次对外投资符合公司战略规划，有利于进一步推进海外布局，有利于满足客户本地化运营和配套服务 需求，开拓海外市场，更加灵活应对宏观环境影响，提升公司综合竞争能力及整体抗风险能力，符合公 司长期发展战略和投资方向。 智通财经APP讯，凯中精密(002823.SZ)发布公告，为落实海外连接器等精密零组件业务的战略规划布 局，公司拟在泰国投资设立子公司并新建生产基地，投资金额不超过2.5亿元人民币(或等值其他货币)， 包括但不限于购买土地、购建固定资产等相关事项，资金来源为公司自有资金和自筹资金，实际投资金 额以中国及当地主管部门批准金额为准。 ...

Core Viewpoint - The company, Kaizhong Precision (002823.SZ), plans to invest up to 250 million RMB in establishing a subsidiary and new production base in Thailand to enhance its overseas connector and precision component business [1] Investment Details - The investment amount will not exceed 250 million RMB, which includes land purchase and fixed asset construction [1] - Funding sources will be from the company's own funds and self-raised funds, with the actual investment amount subject to approval by Chinese and local authorities [1] Strategic Alignment - This investment aligns with the company's strategic planning and aims to advance its overseas layout [1] - It will help meet local operational and service needs of customers, expand overseas markets, and enhance the company's overall competitiveness and risk resistance [1] - The initiative is consistent with the company's long-term development strategy and investment direction [1]

人民财讯8月13日电，凯中精密（002823）8月13日晚间公告，为落实海外连接器等精密零组件业务的战 略规划布局，公司拟在泰国投资设立子公司并新建生产基地，投资金额不超过2.5亿元人民币(或等值其 他货币)。 ...

Core Viewpoint - The company, Shenzhen Kaizhong Precision Technology Co., Ltd., plans to establish a subsidiary and build a production base in Thailand to enhance its overseas connector and precision component business strategy [2] Investment Details - The investment amount for the new subsidiary and production base in Thailand is not to exceed 250 million RMB, which includes purchasing land and constructing fixed assets [2] - The funding sources for this investment will be the company's own funds and self-raised funds, with the actual investment amount subject to approval by Chinese and local authorities [2]

General Provisions - The company aims to protect the legal rights of shareholders, employees, and creditors while regulating its organization and behavior according to relevant laws [1][2] - Shenzhen Kaizhong Precision Technology Co., Ltd. was established as a joint-stock company based on the net asset value of Shenzhen Kaizhong Electric Motor Commutator Co., Ltd. [1][2] - The company was approved by the China Securities Regulatory Commission for its initial public offering of 36 million shares on November 24, 2016 [1][2] Business Objectives and Scope - The company's business objective is to leverage its competitive advantages in the industry to achieve high-quality and efficient operations, ensuring satisfactory returns for shareholders [1][2] - The registered capital of the company is RMB 328,368,949, and its business scope includes the research and sales of various electrical components and products [1][2] Shares - The company issues shares in the form of stocks, with each share having a nominal value of RMB 1 [2] - The total number of shares issued by the company is 328,368,949, all of which are ordinary shares [2] Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends, request meetings, supervise company operations, and transfer their shares according to legal regulations [3][4] - Shareholders are obligated to comply with laws and the company's articles of association, pay for their subscribed shares, and not misuse their rights to harm the company or other shareholders [8][9] Shareholder Meetings - The company holds annual and temporary shareholder meetings, with the annual meeting required to be held within six months after the end of the previous fiscal year [10][11] - Shareholder meetings must be convened in accordance with legal procedures, and the company must provide adequate notice to shareholders [12][13] Decision-Making and Voting - The company’s board of directors is responsible for convening shareholder meetings and must ensure that all decisions comply with legal and regulatory requirements [14][15] - Shareholders can propose agenda items for meetings, and decisions require a majority vote unless otherwise specified [16][17]

Core Points - The document outlines the operational guidelines for the General Manager of Shenzhen Kaizhong Precision Technology Co., Ltd, aiming to enhance corporate governance and ensure effective management [2][3] Group 1: General Provisions - The company establishes a General Manager to oversee daily operations and report to the Board of Directors [2] - The General Manager is responsible for implementing board decisions and managing the company's production and operations [2][3] Group 2: Qualifications and Appointment Procedures - The General Manager and senior management must possess extensive economic and management knowledge, practical experience, and strong management capabilities [3] - Specific disqualifications for the General Manager include criminal convictions related to corruption or financial misconduct [4][5] Group 3: Responsibilities of the General Manager - The General Manager is tasked with organizing the company's annual operational plans and investment proposals [6][8] - The General Manager must report to the Board on significant operational issues and ensure compliance with legal and regulatory requirements [12][13] Group 4: Reporting System - The General Manager is required to report work progress to the Board regularly and must communicate any major issues immediately [12][13] - Reports should include the company's long-term development plans, annual plan implementation, and significant contracts [12][13] Group 5: Performance Evaluation and Incentives - The performance of the General Manager is evaluated by the Board, linking compensation to company performance and individual achievements [31][32] - Violations of laws or negligence leading to company losses may result in penalties or legal action against the General Manager [33]

（2025 年 8 月） 第一章 总则 深圳市凯中精密技术股份有限公司 董事会审计委员会实施细则 深圳市凯中精密技术股份有限公司 董事会审计委员会实施细则 第一条 为充分发挥审计委员会对深圳市凯中精密技术股份有限公司（以下 简称"公司"或"本公司"）财务信息、内部控制、内外部审计等工作的监督作用， 健全公司内部监督机制，完善公司治理结构，根据《中华人民共和国公司法》 《上 第三条 审计委员会成员由 3 名董事组成，应当为不在公司担任高级管理人 员的董事，独立董事过半数，委员中至少有一名独立董事为专业会计人士。 第四条 审计委员会委员由董事长、二分之一以上独立董事或者全体董事的 三分之一提名，并由董事会选举产生。 市公司治理准则》《上市公司独立董事管理办法》《深圳证券交易所上市公司自 律监管指引第 1 号——主板上市公司规范运作》《深圳市凯中精密技术股份有 限公司章程》（以下简称"《公司章程》"）及其他有关规定，公司特设立董事会 审计委员会，并制订本实施细则。 第二条 董事会审计委员会是董事会按照股东会决议设立的专门工作机构， 主要负责审核公司财务信息及其披露、监督及评估内外部审计工作和内部控制工 作，并行使《 ...

深圳市凯中精密技术股份有限公司 投资者关系管理制度 深圳市凯中精密技术股份有限公司 投资者关系管理制度 第二条 投资者关系管理是指公司通过便利股东权利行使、信息披露、互动交 流和诉求处理等工作，加强与投资者及潜在投资者之间的沟通，增进投资者对上市 公司的了解和认同，以提升上市公司治理水平和企业整体价值，实现尊重投资者、 回报投资者、保护投资者目的的相关活动。 第三条 投资者关系管理的基本原则: （一）合规性原则。公司投资者关系管理应当在依法履行信息披露义务的基础 上开展，符合法律、法规、规章及规范性文件、行业规范和自律规则、公司内部规 章制度，以及行业普遍遵守的道德规范和行为准则。 （二）平等性原则。公司开展投资者关系管理活动，应当平等对待所有投资者， 尤其为中小投资者参与活动创造机会、提供便利。 （三）主动性原则。公司应当主动开展投资者关系管理活动，听取投资者意见 建议，及时回应投资者诉求。 深圳市凯中精密技术股份有限公司 投资者关系管理制度 （四）诚实守信原则。公司在投资者关系管理活动中应当注重诚信、坚守底线、 规范运作、担当责任，营造健康良好的市场生态。 第四条 投资者关系管理的目的： （一）促进公司与 ...

深圳市凯中精密技术股份有限公司 董事会议事规则 董事会议事规则 （2025 年 8 月） 第一章 总则 第一条 为了进一步规范深圳市凯中精密技术股份有限公司（以下简称"公 司"或"本公司"）董事会的议事方式和决策程序，促使董事和董事会有效地履 行其职责，提高董事会规范运作和科学决策水平，根据《中华人民共和国公司法》 （以下简称"《公司法》"）《上市公司治理准则》《深圳证券交易所股票上市 规则》（以下简称"《股票上市规则》"）和《深圳市凯中精密技术股份有限公 司章程》（以下简称"《公司章程》"）等有关规定，制订本议事规则。 第二条 董事会是公司的经营决策机构，对股东会负责，执行股东会决议， 依照《公司章程》的规定行使职权。 第三条 董事会下设董事会秘书处，处理董事会日常事务，保管董事会印章。 第二章 董事会的组成 第四条 董事会由九名董事组成，其中独立董事三名，职工代表董事一名。 董事会设董事长一人，董事长由董事会以全体董事的过半数选举产生。 深圳市凯中精密技术股份有限公司 第五条 董事会成员的构成应充分考虑"董事会多元化"政策的原则，包括 但不限于性别、年龄、地区、文化及教育背景、行业经验、专业技能、主要经历 ...